Petco Health + Wellness Company, Inc. Reports Second Quarter Earnings

Author's Avatar
Aug 24, 2023

PR Newswire

Q2 2023 Operating Results

  • Comparable sales grew 3.2 percent year-over-year and 7.0 percent on a two-year basis, resulting in the 19th consecutive quarter of comparable sales growth
  • Net revenue of $1.53 billion increased 3.4 percent year-over-year
  • Net loss of $14.6 million, or $(0.05) per share compared to net income of $13.5 million, or $0.05 per share in the prior year
  • Adjusted Net Income1 decreased $27.2 million to $16.3 million
  • Adjusted EBITDA1 of $112.6 million compared to $133.5 million in the prior year
  • Adjusted Earnings Per Share1 of $0.06, compared to $0.16 per share in the prior year
  • Operating Cash Flow of $96.6 million compared to $42.6 million in the prior year
  • Free Cash Flow1 of $44.6 million, compared to $(27.7) million in the prior year

SAN DIEGO, Aug. 24, 2023 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (Nasdaq: WOOF), a complete partner in pet health and wellness, today announced its second quarter 2023 financial results.

Petco_Logo.jpg

In the second quarter of 2023, Petco delivered net revenue of $1.53 billion, up 3.4 percent versus prior year, driven by strength in the company's consumables business, up 6.8 percent versus prior year, and services and other business, up 30.6 percent versus prior year. Second quarter revenue growth was partially offset by the company's supplies and companion animal business, down 9.4 percent versus prior year. Net loss was $14.6 million or $(0.05) per share, driven in part by a $0.04 per share increase in interest expense year-over-year, compared to net income of $13.5 million or $0.05 per share in the prior year. Adjusted Net Income1 was $16.3 million or $0.06 per share, compared to $43.5 million or $0.16 per share in the prior year. Adjusted EBITDA1 was $112.6 million compared to $133.5 million in the prior year.

"We continue to focus on execution through an uncertain environment, delivering our 19th consecutive quarter of comp sales growth, with ongoing strength in consumables and services, particularly in vet," said Petco CEO Ron Coughlin. "With discretionary spending continuing to be pressured, we're taking numerous strategic actions to strengthen our business, including initiatives to unlock a targeted $150 million in cost savings and productivity enhancements by the end of fiscal 2025. These actions, combined with the enduring competitive advantages of our differentiated offering, will position us even better to deliver sustainable and profitable growth for the long term."

"In Q2, we delivered solid top line results and strong free cash flow," said Petco CFO Brian LaRose. "That said, the shift in consumer spending and pressures on our discretionary business mean we're revising our guidance accordingly. Looking ahead, we remain focused on debt paydown and cash flow, both of which will be supported by our productivity initiatives in addition to tightly controlled expense management."

In the second quarter of 2023, Petco paid down $25 million in principal on its term loan. In August, the company further paid down an additional $15 million in principal on its term loan for a total of $75 million in principal payments year-to-date. The company continues to target a total of $100 million in principal payments for fiscal 2023 and remains committed to strengthening its balance sheet through de-levering.

The company also initiated a cost action plan in the quarter and estimates annualized gross run rate cost savings of $150 million by the end of fiscal 2025, from merchandise, supply chain, and G&A categories. In year one, the company expects to achieve $40 million in savings. In Q2 2023, the company recorded $6 million in headcount reduction-related charges related to the cost action plan.

(1)

Adjusted EBITDA, Adjusted Net Income, Adjusted Earnings Per Share ("Adjusted EPS"), and Free Cash Flow are non-GAAP financial measures. See "Non-GAAP Financial Measures" for additional information on non-GAAP financial measures and a reconciliation to the most comparable GAAP measures.

Fiscal 2023 Guidance:

The company is updating its fiscal 2023 guidance for Adjusted EBITDA, Adjusted EPS and Capital Expenditures and now expects:

Metric*

2023 Guidance

Net Revenue

$6.150 billion to $6.275 billion

Adjusted EBITDA

$460 million to $480 million

Adjusted EPS

$0.24 to $0.30

Capital Expenditures

$215 million to $225 million

*Assumptions in the guidance include that economic conditions, currency rates and the tax and regulatory landscape remain generally consistent. Adjusted EPS guidance assumes approximately $145 to $155 million of interest expense, an estimated $43 to $53 million increase in interest expense year-over-year, a 26 percent tax rate, and a 269 million weighted average diluted share count. The Company estimates that the increase in interest expense will impact Adjusted EPS by approximately $0.12 to $0.15 per share. Furthermore, Fiscal 2023 will be a 53-week year, leading to an incremental week of operations. Adjusted EBITDA and Adjusted EPS are non-GAAP financial measures and have not been reconciled to the most comparable GAAP outlook because it is not possible to do so without unreasonable efforts due to the uncertainty and potential variability of reconciling items, which are dependent on future events and often outside of management's control and which could be significant. Because such items cannot be reasonably predicted with the level of precision required, we are unable to provide outlook for the comparable GAAP measures. Forward-looking estimates of Adjusted EBITDA and Adjusted EPS are made in a manner consistent with the relevant definitions and assumptions noted herein and in our filings with the Securities and Exchange Commission.

Earnings Conference Call Webcast Information:

Management will host an earnings conference call on August 24, 2023 at 8:00 AM Eastern Time to discuss the company's financial results. The conference call will be accessible through a live webcast. Interested investors and other individuals can access the webcast, earnings release, earnings presentation, and infographic via the company's investor relations page at ir.petco.com. A replay of the webcast will be archived on the company's investor relations page through September 7, 2023 until approximately 5:00PM Eastern Time.

About Petco, The Health + Wellness Co.:

Founded in 1965, Petco is a category-defining health and wellness company focused on improving the lives of pets, pet parents and our own Petco partners. We've consistently set new standards in pet care while delivering comprehensive pet wellness products, services and solutions, and creating communities that deepen the pet-pet parent bond. We operate more than 1,500 pet care centers across the U.S., Mexico and Puerto Rico, which offer merchandise, companion animals, grooming, training and a growing network of on-site veterinary hospitals and mobile veterinary clinics. Our complete pet health and wellness ecosystem is accessible through our pet care centers and digitally at petco.com and on the Petco app. In tandem with Petco Love, a life-changing organization, we work with and support thousands of local animal welfare groups across the country and, through in-store adoption events, we've helped find homes for nearly 7 million animals.

Forward-Looking Statements:

This earnings release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, concerning expectations, beliefs, plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are not statements of historical fact, including statements regarding our fiscal year 2023 guidance. Such forward-looking statements can generally be identified by the use of forward-looking terms such as "believes," "expects," "may," "intends," "will," "shall," "should," "anticipates," "opportunity," "illustrative," or the negative thereof or other variations thereon or comparable terminology. Although Petco believes that the expectations and assumptions reflected in these statements are reasonable, there can be no assurance that these expectations will prove to be correct or that any forward-looking results will occur or be realized. Nothing contained in this earnings release is, or should be relied upon as, a promise or representation or warranty as to any future matter, including any matter in respect of the operations or business or financial condition of Petco. All forward-looking statements are based on current expectations and assumptions about future events that may or may not be correct or necessarily take place and that are by their nature subject to significant uncertainties and contingencies, many of which are outside the control of Petco. Forward-looking statements are subject to a number of risks, uncertainties and other factors that could cause actual results or events to differ materially from the potential results or events discussed in the forward-looking statements, including, without limitation, those identified in this earnings release as well as the following: (i) increased competition (including from multi-channel retailers and e-Commerce providers); (ii) reduced consumer demand for our products and/or services; (iii) our reliance on key vendors; (iv) our ability to attract and retain qualified employees; (v) risks arising from statutory, regulatory and/or legal developments; (vi) macroeconomic pressures in the markets in which we operate, including inflation and prevailing interest rates; (vii) failure to effectively manage our costs; (viii) our reliance on our information technology systems; (ix) our ability to prevent or effectively respond to a data privacy or security breach; (x) our ability to effectively manage or integrate strategic ventures, alliances or acquisitions and realize the anticipated benefits of such transactions; (xi) economic or regulatory developments that might affect our ability to provide attractive promotional financing; (xii) business interruptions and other supply chain issues; (xiii) catastrophic events, political tensions, conflicts and wars (such as the ongoing conflict in Ukraine), health crises, and pandemics; (xiv) our ability to maintain positive brand perception and recognition; (xv) product safety and quality concerns; (xvi) changes to labor or employment laws or regulations; (xvii) our ability to effectively manage our real estate portfolio; (xviii) constraints in the capital markets or our vendor credit terms; (xix) changes in our credit ratings; and (xx) the other risks, uncertainties and other factors identified under "Risk Factors" and elsewhere in Petco's Securities and Exchange Commission filings. The occurrence of any such factors could significantly alter the results set forth in these statements.

Petco cautions that the foregoing list of risks, uncertainties and other factors is not complete, and forward-looking statements speak only as of the date they are made. Petco undertakes no duty to update publicly any such forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required by applicable law, regulation or other competent legal authority.

PETCO HEALTH AND WELLNESS COMPANY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(Unaudited and subject to reclassification)

13 Weeks Ended

July 29,
2023

July 30,
2022

Percent
Change

Net sales

$ 1,530,734

$ 1,480,797

3 %

Cost of sales

937,730

886,320

6 %

Gross profit

593,004

594,477

(0 %)

Selling, general and administrative expenses

568,967

544,472

4 %

Operating income

24,037

50,005

(52 %)

Interest income

(764)

(137)

458 %

Interest expense

37,493

21,820

72 %

Loss on partial extinguishment of debt

305

N/M

Other non-operating (income) loss

(1,795)

10,259

N/M

(Loss) income before income taxes and income from
equity method investees

(11,202)

18,063

N/M

Income tax expense

6,732

6,638

1 %

Income from equity method investees

(3,328)

(2,031)

64 %

Net (loss) income

(14,606)

13,456

N/M

Net loss attributable to noncontrolling interest

N/M

Net (loss) income attributable to Class A and B-1 common
stockholders

$ (14,606)

$ 13,456

N/M

Net (loss) income per Class A and B-1 common share:

Basic

$ (0.05)

$ 0.05

N/M

Diluted

$ (0.05)

$ 0.05

N/M

Weighted average shares used in computing net (loss) income per Class A
and B-1 common share:

Basic

267,163

265,431

1 %

Diluted

267,163

265,835

0 %

PETCO HEALTH AND WELLNESS COMPANY, INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except per share amounts)

(Unaudited and subject to reclassification)

July 29,
2023

January 28,
2023

ASSETS

Current assets:

Cash and cash equivalents

$

173,014

$

201,901

Receivables, less allowance for credit losses1

66,258

49,580

Merchandise inventories, net

675,441

652,430

Prepaid expenses

54,880

51,274

Other current assets

55,247

60,809

Total current assets

1,024,840

1,015,994

Fixed assets

2,090,367

1,987,560

Less accumulated depreciation

(1,270,141)

(1,184,233)

Fixed assets, net

820,226

803,327

Operating lease right-of-use assets

1,401,834

1,397,761

Goodwill

2,196,664

2,193,941

Trade name

1,025,000

1,025,000

Other long-term assets

193,698

176,806

Total assets

$

6,662,262

$

6,612,829

LIABILITIES AND EQUITY

Current liabilities:

Accounts payable and book overdrafts

$

477,748

$

381,213

Accrued salaries and employee benefits

90,796

89,929

Accrued expenses and other liabilities

219,910

217,556

Current portion of operating lease liabilities

281,415

309,766

Current portion of long-term debt and other lease liabilities

5,077

22,794

Total current liabilities

1,074,946

1,021,258

Senior secured credit facilities, net, excluding current portion

1,588,523

1,628,331

Operating lease liabilities, excluding current portion

1,159,696

1,148,155

Deferred taxes, net

294,094

303,121

Other long-term liabilities

130,239

130,487

Total liabilities

4,247,498

4,231,352

Commitments and contingencies

Stockholders' equity:

Class A common stock2

230

228

Class B-1 common stock3

38

38

Class B-2 common stock4

Preferred stock5

Additional paid-in-capital

2,196,235

2,152,342

Retained earnings

216,470

232,967

Accumulated other comprehensive income (loss)

1,791

(4,098)

Total stockholders' equity

2,414,764

2,381,477

Total liabilities and stockholders' equity

$

6,662,262

$

6,612,829

(1)

Allowances for credit losses are $1,164 and $952, respectively

(2)

Class A common stock, $0.001 par value: Authorized - 1.0 billion shares; Issued and outstanding - 229.8 million and 228.3 million shares, respectively

(3)

Class B-1 common stock, $0.001 par value: Authorized - 75.0 million shares; Issued and outstanding - 37.8 million shares

(4)

Class B-2 common stock, $0.000001 par value: Authorized - 75.0 million shares; Issued and outstanding - 37.8 million shares

(5)

Preferred stock, $0.001 par value: Authorized - 25.0 million shares; Issued and outstanding - none

PETCO HEALTH AND WELLNESS COMPANY, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited and subject to reclassification)

26 Weeks Ended

July 29,
2023

July 30,
2022

Cash flows from operating activities:

Net (loss) income

$

(16,498)

$

37,258

Adjustments to reconcile net (loss) income to net cash provided by
operating activities:

Depreciation and amortization

97,919

95,570

Amortization of debt discounts and issuance costs

2,446

2,456

Provision for deferred taxes

(11,002)

9,216

Equity-based compensation

46,248

25,117

Impairments, write-offs and losses on sale of fixed and other assets

1,035

1,369

Loss on partial extinguishment of debt

746

Amounts reclassified out of accumulated other comprehensive income (loss)

1,055

Income from equity method investees